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Abstract 
 
Aldosterone increases sodium reabsorption across kidney target tubules already before it 
increases the number of transport proteins, indicating that the early functional response to 
aldosterone depends on the activation of preexisting channels and pumps. A central mediator of 
this action is the early aldosterone-induced kinase Sgk1 that de-represses the surface 
expression and activity of the epithelial sodium channel (ENaC). A main mechanism by which 
Sgk1 exerts this de-repression is the phosphorylation of the ubiquitin ligase Nedd4-2 that is 
thereby prevented from ubiquitylating ENaC. Among a series of new early aldosterone-induced 
gene products recently identified in kidney target tubules, an additional regulator of ENaC 
ubiquitylation, the deubiquitylating enzyme Usp2-45, was identified. Co-expression of Usp2-45 
was shown to increase ENaC surface expression and activity and to decrease its ubiquitylation 
in expression systems, whereas other Usp’s such as the splice variant Usp2-69 had no effect. 
Since both Sgk1 and Usp2-45 are similarly induced in distal colon as well, in contrast to other 
gene products strongly induced kidney that are not regulated in colon, we suggest that 
(de)ubiquitylation is the major ENaC regulatory mechanism targeted by aldosterone in the short-
term via transcriptional regulation. 
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Sodium transport regulation by aldosterone in ASDN: functional aspects 
 
The mineralocorticoid hormone aldosterone has a short half-live and its level follows the 
circadian rhythm and also rapidly fluctuates with homeostatic needs. Its best known effect is to 
increase sodium reabsorption across target epithelia expressing the epithelial sodium channel 
ENaC, the mineralocorticoid receptor (MR) and the “glucocorticoid-protective” enzyme 11β-
hydroxysteroid dehydrogenase type 2, as it is the case in the aldosterone-sensitive distal 
nephron (ASDN) [1]. The electrogenic sodium reabsorption mediated by luminal ENaC and the 
basolateral Na,K-ATPase starts increasing in ASDN within 30 min of aldosterone addition. 
Depending on the physiological conditions and on the regulatory state of WNK4, electric 
neutrality of the transepithelial sodium transport is maintained to a variable extent by co-
reabsorption of Cl- (NaCl reabsorption) and/or K+ secretion (Na+/K+ exchange)  [1, 2].  
This review focuses on the mechanism that governs the early regulation of sodium reabsorption 
by aldosterone. As discussed below, it appears that the main intracellular signaling system 
targeted by aldosterone in the short term is an ubiquitylation pathway that otherwise exerts a 
tonic inhibition on ENaC functional surface expression [3, 4]. When the aldosterone stimulation 
persists for a longer time, additional regulatory actions develop [1]. This does not mean that the 
short-term activation mechanism is then interrupted, but that additional effects are taking place 
that might on the one hand strengthen the response and on the other hand, as anabolic action, 
reinforce the machinery in view of long term transport activity. Such an aldosterone-induced 
differentiation of ASDN cells expressing ENaC-mediated Na+ reabsorption has been observed 
morphologically many years ago and shown to depend not only on the presence of aldosterone 
but also on a number of other factors, one of which is the availability of Na+ in the tubular lumen 
[5, 6]. 
Earlier studies aiming at understanding how aldosterone induces an increase in Na+ transport 
across its kidney target cells followed a candidate approach and focused on the transport 
proteins ENaC and Na,K-ATPase and on elements of the energy metabolism [7, 8]. That both 
the luminal channel ENaC and the basolateral pump Na,K-ATPase are indeed regulated by 
aldosterone has been verified, but these anabolic-type effects were shown to belong to a slightly 
delayed action although they are to some extent initiated immediately by changes in the 
transcription rate of some of the genes encoding these transport proteins [7].  
The so called early effects of aldosterone have attracted much interest also because they are 
more amenable to mechanistic studies than many long term effects. A great technical 
advantage is the lack of overlap of their early start with potential secondary effects. However, a 
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complication that has to be taken in account is the fact that aldosterone apparently also exerts 
so-called non genomic effects the nature of which is apparently multiple, involving potential 
direct effects, membrane receptor(s), the mineralocorticoid receptor MR and MR-associated 
proteins [9]. In the next section, we will briefly review aldosterone-induced gene products that 
have been identified and studied in the past years and in later sections we will focus on the 
ubiquitylation-deubiquitylation pathway that regulates ENaC surface expression with particular 
emphasis on the aldosterone regulated players: Sgk1 that inhibits the function of the ENaC 
ubiquitin ligase Nedd4-2 and Usp2-45, a newly identified deubiquitylating enzyme that targets 
ENaC (Fig. 1).  
 
Previously identified early aldosterone-regulated gene products acting on the ion 
transporting machinery 
 
The classical mechanism by which aldosterone acts in its target cells is by activating the 
mineralocorticoid receptor (MR) that belongs to the family of nuclear receptors. In particular its 
stimulatory action on Na+ reabsorption in kidney distal nephron has indeed been shown to 
mostly depend on transcriptional regulation whereas other actions appear to be independent of 
transcriptional regulation  [1, 9]. Over the past decade a number of gene products that are 
induced by aldosterone have been identified mostly in cell culture systems and in some cases a 
possible role in mediating the early aldosterone-induced increase in sodium reabsorption has 
been shown experimentally, generally using expression systems. 
Clearly the most studied and apparently central player is Sgk1, a kinase belonging to the AGC 
family of serine/threonine protein kinases that similarly to Akt/protein kinase B needs to be itself 
activated via 3-phosphoinositide-dependent kinases PDK1 and 2. Sgk1 has been identified first 
in cultured cells and its regulation has been verified in vivo in kidney ASDN and distal colon [10, 
11]. A short section will be dedicated to this important player that interferes with the ENaC 
ubiquitylation pathway.  
The first early aldosterone-induced gene product that was identified and shown in an expression 
system to stimulate the function of ENaC is K-Ras2 [12]. It has to be mentioned that it was 
identified in an amphibian model cell line (A6) and that its early regulation by aldosterone was 
not verified in mouse kidney target tubules but in mouse distal colon [13]. In any case, this small 
G protein via its effector protein PI3-kinase stimulates ENaC activity via the PDK-Sgk pathway 
(Fig. 1 and see below) and possibly also via direct effects of its phospholipid product PI(3,4,5)P 
on ENaC function [14]). 
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Another aldosterone-regulated gene product that has been identified in cell culture and the 
induction of which has been verified in kidney tubule is GILZ, a member of the TSC22 family of 
leucine zipper proteins [15]. This gene product has been shown to prevent activation of Raf, 
another downstream effector of Ras, and thereby to prevent the inhibitory action of Erk1/2 on 
ENaC [16]. Interestingly, Erk-mediated inhibition of ENaC appears to involve channel 
phosphorylation that stimulates interaction with Nedd4 ubiquitin ligases (Fig. 1). Thus, the 
stimulatory action of GILZ on ENaC activity is mediated, similarly to that of Sgk1, by the release 
of ENaC from the tonic inhibition mediated by Nedd4-2 [4]. 
The mechanism of action of the three early aldosterone-induced proteins mentioned above have 
been shown to stimulate ENaC to a large extend by interfering with the tonic inhibitory action of 
Nedd4 proteins. Other potential early aldosterone-induced regulatory proteins acting on ENaC 
function are for instance 14-3-3 protein isoforms β and ε that participate to the inhibition of 
Nedd4-2 mediated by Sgk1 and N-Myc downstream-regulated gene 2 (NDRG2), the 
mechanism of action of which has not yet been clarified [17, 18]. Also the kidney-specific WNK1 
isoform (KS-WNK1) has been shown to be induced by aldosterone in a cell culture model and 
might participate to the aldosterone action on sodium transport [19]. 
 
Role of Nedd4-2 in ENaC regulation 
 
ENaC has been shown to be regulated by ubiquitylation (also referred to as ubiquitination or 
ubiquitinylation), a post-translational modification involving the ligation of (a) ubiquitin 
polypeptide(s) [20]. Although ubiquitylation has originally been recognized as a degradation 
signal for cytosolic proteins, it is now clear that this posttranslational modification plays an 
essential role in the regulation of basically any kind of cellular function. Importantly, 
ubiquitylation is reversible and correspondingly a large number of different deubiquitylating 
enzymes have been identified as well.   
Ubiquitylation of target proteins involves an enzymatic cascade. The first step of this cascade is 
binding of ubiquitin by a thioester to a cystein residue of the E1 ubiquitin-activating enzyme, a 
reaction requiring ATP. Ubiquitin is then transferred onto an E2 enzyme, also as thioester. 
Finally, it is an E3 enzyme, or ubiquitin-protein ligase that provides substrate recognition and 
promotes transfer of ubiquitin to the target protein to which it is then linked by an isopeptide 
bond at the level of the ε-amino group of a lysine residue. The various E3 enzymes work by one 
of the two following mechanisms. Ligases that contain a RING finger motif, promote the direct 
transfer of ubiquitin from the E2 enzyme onto the target protein, whereas the so-called HECT 
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domain containing E3 ligases, to which Nedd4-2 belongs, form first a thioester between the 
ubiquitin and their HECT domain, and then transfer the ubiquitin onto the target protein. These 
targets can be differentially ubiquitylated, for instance mono-ubiquitylated (one mono-ubiquitin), 
multi-ubiquitylated (several mono-ubiquitins each on a different lysine) or polyubiquitylated (one 
or multiple chains of ubiquitins linked together via internal lysines, mostly K48 and K63). This 
differential ubiquitylation allows the generation of a multitude of different signals. 
The fact that ubiquitylation plays a major role for ENaC regulation was revealed by the 
investigation of the defect underlying Liddle’s syndrome. This rare hereditary form of salt-
sensitive hypertension is autosomal dominant and accompanied by hypokalemia, metabolic 
acidosis and low circulating levels of renin and aldosterone. The increased sodium reabsorption 
observed in this condition was shown to be caused by mutations within the genes encoding β or 
γENaC leading to the deletion or mutation of the so-called PY-motif located in the cytoplasmic 
COOH-termini of these subunits [21]. The first evidence that ENaC may be regulated by 
ubiquitylation came from the finding that these PY-motifs (xPPxY) act as binding sites for the 
WW protein-protein interaction domains of ubiquitin-protein ligases belonging to the 
Nedd4/Nedd4-like family, in particular Nedd4-2 [22]. Indeed, the work of many laboratories has 
confirmed that ENaC is a protein complex with a rapid turnover, which is ubiquitylated in a 
Nedd4-2 dependant manner [3]. Ubiquitylation by Nedd4-2 decreases ENaC cell surface 
expression [22] primarily by enhancing its internalization and also by interfering with its cAMP 
dependant translocation to the surface from a subapical pool and by stimulating its targeting to 
the lysosomal/endosomal pathway  [23].  
Several important aspects of this type of regulation have been described recently. As outlined 
above, proteins can for instance be either mono-, multi- or polyubiquitylated [24]. Whereas 
membrane receptors appear often to be regulated by mono-ubiquitylation [25], the case of 
ENaC is less clear. It appears that ENaC can be mono- or multi-ubiquitylated, but also poly-
ubiquitylated [23, 26, 27]. Wiemuth et al. chose an indirect approach to show that an antibody 
specific for polyubiquitylation does not  detect ubiquitylated species of ENaC at the cell surface 
of transfected COS cells, suggesting that ENaC is either mono- or multiubiquitylated at the 
plasma membrane [26]. A caveat may be that in these experiments single ENaC subunits were 
transfected, and hence this may not represent the normal situation for ENaC, that is composed 
of three subunits. Another approach has been chosen by Snyder and collaborators, who in 
contrast showed that cell-surface ENaC can be either mono-, multi- or polyubiquitylated [27]. To 
determine if mono-ubiquitylation is involved in ENaC cell surface expression, they expressed an 
ubiquitin variant with mutated lysine residues that cannot participate to polyubiquitylation. This 
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manipulation increased the amount of βENaC at the cell surface, suggesting that poly-
ubiquitylation restricts ENaC cell surface expression. On the other hand, overexpression of 
Nedd4-2 together with this lysine-less ubiquitin variant still caused a downregulation of ENaC 
activity, suggesting that mono- or multi-ubiquitylation also may play a role.  
The physiological relevance of the mechanistic questions discussed above remain to some 
extent open, since so far no knockout model for Nedd4-2 is available. However, direct evidence 
for a role of Nedd4-2 was obtained in Fisher rat thyroid cells transfected with ENaC subunits, in 
which RNA interference experiments demonstrated that suppression of Nedd4-2, but not of its 
close paralogue Nedd4-1, causes an increase in transepithelial Na+ transport [28]. Moreover 
there are several genetic studies which associate polymorphisms of Nedd4-2 with blood 
pressure variations in human population [29-32]. Finally it is apparent that Nedd4-2 dependant 
ubiquitylation of ENaC is regulated physiologically by various mechanisms. For instance, 
Loffing-Cueni and collaborators showed that varying Na+ diet influences Nedd4-2 expression in 
the ASDN. Specifically, low Na+ diet decreases Nedd4-2, whereas high salt diet increases it. 
Moreover, it was shown that the gradient of Nedd4-2 protein expression that increases along 
the nephron from CNT toward CCD is opposite to that of ENaC [33]. The central role played by 
Nedd4-2-mediated downregulation of ENaC is demonstrated by the fact that hormones such as 
aldosterone and vasopressin that stimulate Na+ reabsorption actually act by antagonizing this 
Nedd4-2-mediated ubiquitylation of ENaC (Fig. 1, see below). A major player for this Nedd4-2 
antagonism is Sgk1 that has been shown to bind to Nedd4-2 and to phosphorylate it, thereby 
providing docking sites for 14-3-3 proteins. The association of these 14-3-3 proteins with 
Nedd4-2 is then thought to prevent binding of Nedd4-2 to ENaC and thereby to cause a 
reduction in ENaC ubiquitylation leading to an accumulation of ENaC at the plasma membrane 
[34-36]. Similarly to Sgk1, PKA [37], GRK2 [38, 39] and Akt [40] are able to phosphorylate 
Nedd4-2, showing that this ubiquitin ligase also functions as a site of regulatory convergence. 
 
Sgk1: a point of regulatory convergence 
 
The early aldosterone-induced protein Sgk1 is a ubiquitous kinase that has been shown to 
target directly or indirectly the function of many other transport proteins, besides its Nedd4-2-
mediated action on ENaC mentioned above [41]. In the context of aldosterone action, it is 
noteworthy to mention that Sgk1 has recently been shown to also increase αENaC transcription 
by inhibiting histone methylation in its promoter region [42].   Despite these important roles in 
mediating the effect of aldosterone on ENaC, Sgk1 knock out mice are viable and present 
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normal blood pressure and kidney function when fed normal diet [43]. That Sgk1 nonetheless 
plays a regulatory role in these conditions is indicated by a slightly elevated aldosterone level. 
The fact that Sgk1 plays a crucial role for compensating a low Na+ intake was shown by the fact 
that Sgk1 knock out mice display decreased blood pressure and glomerular filtration rate under 
low Na+ diet conditions. The kidney phenotype of these mice being much less severe than that 
of the mineralocorticoid receptor (MR) knock out mice confirms that Sgk1 is not the only 
mediator through which aldosterone stimulates and supports Na+ reabsorption. For the short 
term regulation of ENaC function, it appears however to play a central role within the regulatory 
network, by integrating inputs from different regulatory pathways and translating them into a 
graded release of ENaC from Nedd4-2-mediated inhibition. Sgk1 is regulated on the one hand 
at the level of its transcription, in particular by aldosterone via MR, and also by other hormones 
such as glucocorticoids. On the other hand it is regulated at the level of its function by its 
phosphorylation, in particular by the PDK kinases that mediate stimulatory effects of hormones 
such as IGF and Insulin that stimulate the PI3-kinase pathway, and possibly also by PKA that 
mediates the effect of hormones such as vasopressin (ADH) (Fig. 1) [44, 45]. Thus, 
transcriptional and posttranslational regulations of Sgk1 act synergistically. An other less well 
understood aspect of the control of Sgk1 function is its subcellular localization for which also 
posttranslational modifications such as phosphorylation and also interactions with other proteins 
certainly play an important role [46]. 
 
Usp2-45: a new aldosterone-induced player 
 
In a recent gene expression screen performed on mouse kidney connecting/ collecting ducts, 
Fakitsas et al., identified among 9 mRNAs increased ≥2-fold after 1 h aldosterone also, next to 
Sgk1, the ubiquitin-specific protease Usp2-45 [47]. This deubiquitylating enzyme was shown in 
Xenopus oocytes to increase the function of co-expressed ENaC at the cell surface, whereas 
other tested deubuquitylating enzymes, such as its isoform Usp2-69 had no effect. Interestingly, 
the stimulatory effect of Usp2-45 was at least as important as that of Sgk1 but not additive to it. 
This, as well as the observations that Usp2-45 was not increasing the function of ENaC devoid 
of COOH-terminal PY motif (binding site for Nedd4-2) nor that of ENaC devoid of NH2-terminal 
lysine residues (potential ubiquitylation sites) suggests that Usp2-45 interferes with the same 
Nedd4-2-dependent ubiquitylation as Sgk1. Furthermore, using Hek293 cells, the same authors 
showed that Usp2-45 coexpression strongly decreases the level of ENaC ubiquitylation. Thus, 
aldosterone increases also the deubiquitylation of ENaC. The question remains open whether 
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Usp2-45 by deubiquitylating ENaC and possibly interacting with it plays additional roles in the 
regulation of this channel. It may particularly play a major role in conditions in which aldosterone 
is high but the Nedd4-2 inhibitory function of Sgk1 is not stimulated due to low activity of the 
PI3-kinase and cAMP pathways.  
 
Conclusions and Perspectives 
 
There is an ongoing increase in the number of newly published mechanisms and regulatory 
cross-talks that impact on the function of ENaC, not only confirming that this channel plays a 
central role for the regulation of Na+ reabsorption in aldosterone target epithelia, but also 
supporting the notion that this homeostatically important function is controlled by an intricate 
network encompassing a great number of pathways that are controlled by a myriad of local, 
regional and organismic inputs. The inputs that impact on Na+ transport via ENaC in the short 
term appear to converge onto a dominating repressor system that involves ENaC ubiquitylation 
and deubiquitylation. An important argument supporting this view is the observation that among 
the gene products rapidly and substantially upregulated by aldosterone in kidney and in distal 
colon, Sgk1 and Usp2-45 are the ones with the strongest early regulation and appear to be the 
only ones directly involved in regulating Na+ transport function (Fakitsas P, Wagner U and 
Verrey F, unpublished results)[47]. Importantly, by controlling the level of key regulatory proteins 
of ENaC ubiquitylation/ deubiquitylation, aldosterone sets the level of sensitivity of the Na+ 
transport machinery to the inputs of other signaling pathways, in particular mediated by PI3-
kinase (IGF, Insulin), cAMP (vasopressin) and ERK (Fig. 1). 
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Figure Legends 
 
Figure 1.  Model for the early transcriptional action of aldosterone on ENaC function. The 
ubiquitin ligase Nedd4-2 that tonically inhibits ENaC surface expression is highlighted in red and 
red dashed arrows indicate pathways downregulating ENaC that are antagonized by 
aldosterone. Blue boxes represent the regulatory proteins implicated in the early aldosterone 
action that are rapidly induced via activated mineralocorticoid receptor (MR). The blue lines 
terminated by a dash indicate at what level these regulatory proteins interfere with ENaC 
inhibition. 
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